January 21, 2025
A husband-wife team of veterinary oncologists with expertise in tumor ablation devices is now part of the Purdue University College of Veterinary Medicine’s Department of Veterinary Clinical Sciences and the Evan and Sue Ann Werling Comparative Oncology Research Center. Dr. Nick Dervisis and Dr. Shawna Klahn started in their new roles as Purdue associate professors of comparative oncology August 12 as part of the university’s Moveable Dream Hires program.
January 21, 2025
After providing dedicated and exceptional leadership for the College of Veterinary Medicine’s research programs, Associate Dean for Research and Graduate Programs Harm HogenEsch stepped down in August, concluding his long-standing tenure in that position, which was marked by record-setting success.
January 21, 2025
For Dr. Ourania Andrisani, Distinguished Professor of Basic Medical Sciences, understanding the complexities of liver cancer has been a defining passion throughout her career. Her work marks a critical step toward developing more effective treatments for this devastating disease.
January 17, 2025
The Westwood Lecture Series is part of Purdue President Mung Chiang’s efforts aimed at enhancing the intellectual vibrancy of the Purdue West Lafayette campus, and the next featured speaker is Purdue Veterinary Medicine’s Distinguished Professor of Virology, Dr. Suresh Mittal. His presentation entitled, “Universal Influenza Vaccine — An Aspiration or Reality?” is scheduled for January 28, and registration for the lecture is now open.
January 10, 2025
Known by the acronym AgSEED, the Agricultural Science and Extension for Economic Development program is an internal competitive grants system of the Purdue University College of Agriculture that focuses on advancing Indiana’s leadership in plant and animal agriculture and rural growth, especially through entrepreneurial initiatives. This year, three Purdue Veterinary Medicine faculty members are among 17 recipients of 2025 AgSEED grants.
November 22, 2024
The Purdue University College of Veterinary Medicine, in partnership with Akston Biosciences Corporation, has initiated the enrollment of dogs with urinary bladder cancer in a clinical trial of a pioneering immunotherapy. The strategic partnership between Purdue and Akston was announced in August after the underlying technology was developed at the College of Veterinary Medicine and the Purdue Institute for Cancer Research (PICR).
November 15, 2024
Antimicrobial resistance (AMR) is a growing, significant One Health issue across the world. The WHO estimates that AMR was directly responsible for 1.27 million global deaths and contributed to 4.95 million deaths, with additional significant economic costs. AMR affects all countries and all income groups, and to tackle this urgent problem, researchers, producers, and practitioners from all areas must address the critical shortage of new antimicrobial drugs, and the use of antimicrobial drugs in medicine, farming, and industry. The week of November 18-24 is US Antibiotic Awareness Week and World AMR Awareness Week, and the College of Veterinary Medicine is taking advantage of these national and global campaigns to raise awareness about AMR and antimicrobial stewardship, and to highlight some of the research and practices being conducted at the college to address AMR.
November 15, 2024
When Purdue University’s Office of Research honored the accomplishments and innovative ideas of a host of researchers this week, several Purdue Veterinary Medicine scholars were among those recognized. At a ceremony Wednesday, November 14, in the Purdue Memorial Union North and South Ballrooms, the annual Seed for Success Acorn Awards were presented to Purdue Principal Investigators (PIs) and co-PIs who secured research awards of $1 million or more for a single proposal in fiscal year 2024.
November 15, 2024
Despite more than six decades of research in the field of neuroscience, many functions of the brain — the most complex organ in the human body — remain a mystery. Recent research conducted in the Purdue University College of Veterinary Medicine and the Bindley Bioscience Center revealed that scientists are one step closer to understanding the process that activates and deactivates specific proteins within our cells. This breakthrough could one day lead to enhanced treatments that may slow down or perhaps reverse the advance of neurogenerative diseases such as Alzheimer’s, Parkinson’s and multiple sclerosis.
October 25, 2024
GeniPhys, a preclinical-stage company founded by a Purdue University researcher with ties to the College of Veterinary Medicine, is expected to commercialize a wound management product in the second quarter of 2025 that involves developing regenerative collagen polymeric biomaterials for soft tissue restoration. Collymer SAS was developed by Sherry Harbin, a Purdue professor of biomedical engineering and former professor (now professor by courtesy appointment) in the College of Veterinary Medicine’s Department of Basic Medical Sciences.
